Yes — there is an active recall. 82 ongoing FDA recalls mention Pine (685 total). Check the affected lots below.
Recalls are matched by product description. A recall usually affects specific lots, not every package of Pine. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed.
Reason Incorrect Product Formulation; product was manufactured with the incorrect Art Cherry Flavor flavoring agent instead of Art Black Cherry Flavor…
Reason CGMP Deviations: Intermittent exposure to temperature excursion during storage.
Reason CGMP Deviations: Intermittent exposure to temperature excursion during storage.
Reason CGMP Deviations: Intermittent exposure to temperature excursion during storage.
Reason CGMP Deviations: Intermittent exposure to temperature excursion during storage.
Reason CGMP Deviations: Intermittent exposure to temperature excursion during storage.
Reason CGMP Deviations: Intermittent exposure to temperature excursion during storage.
Reason CGMP Deviations: Intermittent exposure to temperature excursion during storage.
Reason Subpotent drug: Out of specification for assay of naloxone and buprenorphine (low)
Reason Labeling: Incorrect or Missing Lot and/or Exp Date
Reason Lack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unit
Reason Subpotent Drug: Low out-of-specification assay results for the epinephrine component.
Reason Subpotent
Reason Failed impurities/ degradation specifications: Out of specification impurity results were observed during routine testing of stability samples for…
Reason Subpotent Drug
Reason FAILED DISSOLUTION SPECIFICATION: Low out-of-specification (OOS) dissolution results obtained during routine stability testing.
Reason Presence of foreign tablet: Consumer complaint of Clozapine Tablets 50mg being present in 500 count bottles of Clozapine Tablets USP 100mg.
Reason Failed Impurities/ Degradation Specifications
Reason Failed Impurities/ Degradation Specifications
Reason Failed Dissolution Specifications
Reason Presence of Particulate Matter: Fresenius Kabi recalling vials of Ketorolac
Reason CGMP Deviations: Products were manufactured in a processing area in which water leakage was observed
Reason Firm is recalling 46 lots of various products because of a lack of sterility assurance.
Reason CGMP Deviations: Precautions taken due to Out-of-specification for trigger force for a non-marketed lot number that shares the same component.
Reason Labeling; Incorrect or Missing Package Insert: Product was packaged with the package insert for Quetiapine Fumarate Tablets not Quetiapine Fumarate…
Tell us which medications you take. If the FDA recalls one, we email you - in plain English, with what to do. Free.